Video

Managing Patients on PCSK9 Inhibitors

Author(s):

Lauren Santye, Assistant Editor

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses utilization management issues with a PCSK9 inhibitor regimen for high cholesterol.

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses utilization management issues with a PCSK9 inhibitor regimen for high cholesterol.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Pharmacist and doctor -- Image credit: ake1150 | stock.adobe.com
Related Content
Diagnosis papers for chronic kidney disease (CKD) -- Image credit: Dzmitry | stock.adobe.com
August 19th 2025

UNI-494 Receives US Patent for Treatment of Chronic Kidney Disease

Gillian McGovern, Associate Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
August 19th 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Treatment for chronic kidney disease (CKD) -- Image credit: jarun011 | stock.adobe.com
August 19th 2025

Study Finds Biomarkers That May Help Predict, Manage Chronic Kidney Disease

Gillian McGovern, Associate Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
August 19th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Dynamic 3D Visualization of Cholesterol Lowering Process in Bloodstream
August 19th 2025

Lipid-Lowering Effects Discovered in FDA-Approved Drugs Using Machine Learning

Luke Halpern, Assistant Editor
Coffee and tea -- Image credit: yaisirichai | stock.adobe.com
August 19th 2025

Caffeine Consumption Not Associated With Chronic Kidney Disease, Study Finds

Gillian McGovern, Associate Editor